MedTrace Logo

Haelan 951 for Menopause Symptoms in Peri- and Postmenopausal Women

NCT07751029 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2026-08-10

No results posted yet for this study

Summary

This proof-of-concept, open-label, single-arm study is designed to evaluate the effects of daily consumption of Haelan 951, a fermented soy conventional food product, on self-reported menopausal vasomotor symptoms, sleep quality, and health-related quality of life in peri- and postmenopausal women. The study will collect descriptive data on participant-reported outcomes over the study period to assess the feasibility and potential effects of Haelan 951 in supporting menopausal wellness. The study is not intended to evaluate the treatment, prevention, or cure of any disease.

Conditions

  • Menopause
  • Menopause Hot Flashes
  • Menopause Related Conditions

Interventions

DIETARY_SUPPLEMENT

Haelan 951

Haelan 951 is a fermented soy product administered orally once daily for 30 days. Participants will consume the study product according to the protocol to evaluate its effects on self-reported menopausal vasomotor symptoms, sleep quality, and health-related quality of life in peri- and postmenopausal women.

Sponsors & Collaborators

  • Haelan Products, Inc.

    collaborator INDUSTRY

  • NexTrial AI Inc

    collaborator UNKNOWN

  • Spectrum Clinical Research, LLC

    lead NETWORK

Principal Investigators

  • Kelly James, MD · Spectrum Clinical Research

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2026-09-30
Completion
2026-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07751029 on ClinicalTrials.gov